{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:47:49Z","timestamp":1785840469734,"version":"3.56.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,4]]},"DOI":"10.7759\/cureus.113930","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:10:05Z","timestamp":1785838205000},"source":"Crossref","is-referenced-by-count":0,"title":["Improving Lipid Screening Adherence in Inflammatory Arthritis Using a Two-Cycle Plan-Do-Study-Act (PDSA) Quality Improvement Intervention"],"prefix":"10.7759","author":[{"given":"Morgan","family":"Lilly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnoor","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Jagannath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Monga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Introduction: purpose and previous U.S. Preventive Services Task Force recommendation","author":"Chou R","year":"2016","unstructured":"Chou R, Dana T, Blazina I, Daeges M, Bougatsos C, Jeanne T. Introduction: purpose and previous U.S. Preventive Services Task Force recommendation. Screening for Dyslipidemia in Younger Adults: A Systematic Review to Update the 2008 U.S. Preventive Services Task Force Recommendation. Agency for Healthcare Research and Quality (US), Rockville, MD; 2016."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"Avina-Zubieta JA","year":"2012","unstructured":"Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012, 71:1524-9. 10.1136\/annrheumdis-2011-200726","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000999","article-title":"Cardiovascular disease in spondyloarthritis: a narrative review of risk factors and the effect of treatments","volume":"36","author":"Sen R","year":"2024","unstructured":"Sen R, Caplan L, Danila MI. Cardiovascular disease in spondyloarthritis: a narrative review of risk factors and the effect of treatments. Curr Opin Rheumatol. 2024, 36:95-107. 10.1097\/BOR.0000000000000999","journal-title":"Curr Opin Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06473-9","article-title":"Cardiovascular comorbidities in spondyloarthritis","volume":"42","author":"Bodur H","year":"2023","unstructured":"Bodur H. Cardiovascular comorbidities in spondyloarthritis. Clin Rheumatol. 2023, 42:2611-20. 10.1007\/s10067-022-06473-9","journal-title":"Clin Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-023-06655-z","article-title":"Cardiovascular risk in axial spondyloarthritis - a systematic review","volume":"42","author":"Hintenberger R","year":"2023","unstructured":"Hintenberger R, Affenzeller B, Vladychuk V, Pieringer H. Cardiovascular risk in axial spondyloarthritis - a systematic review. Clin Rheumatol. 2023, 42:2621-33. 10.1007\/s10067-023-06655-z","journal-title":"Clin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1254753","article-title":"Dyslipidemia in rheumatoid arthritis: the possible mechanisms","volume":"14","author":"Yan J","year":"2023","unstructured":"Yan J, Yang S, Han L, et al.. Dyslipidemia in rheumatoid arthritis: the possible mechanisms. Front Immunol. 2023, 14:1254753. 10.3389\/fimmu.2023.1254753","journal-title":"Front Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa590","article-title":"Proprotein convertase subtilisin\/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity","volume":"60","author":"de Armas-Rillo L","year":"2021","unstructured":"de Armas-Rillo L, Quevedo-Abeledo JC, de Vera-Gonz\u00e1lez A, et al.. Proprotein convertase subtilisin\/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity. Rheumatology (Oxford). 2021, 60:2296-306. 10.1093\/rheumatology\/keaa590","journal-title":"Rheumatology (Oxford)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204933","article-title":"Inflammation and lipid profile in rheumatoid arthritis: bridging an apparent paradox","volume":"73","author":"Gonz\u00e1lez-Gay MA","year":"2014","unstructured":"Gonz\u00e1lez-Gay MA, Gonz\u00e1lez-Juanatey C. Inflammation and lipid profile in rheumatoid arthritis: bridging an apparent paradox. Ann Rheum Dis. 2014, 73:1281-3. 10.1136\/annrheumdis-2013-204933","journal-title":"Ann Rheum Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000625","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"139","author":"Grundy SM","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, et al.. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019, 139:e1082-143. 10.1161\/CIR.0000000000000625","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters MJ","year":"2010","unstructured":"Peters MJ, Symmons DP, McCarey D, et al.. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2010, 69:325-31. 10.1136\/ard.2009.113696","journal-title":"Ann Rheum Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2013-001862","article-title":"Systematic review of the application of the plan-do-study-act method to improve quality in healthcare","volume":"23","author":"Taylor MJ","year":"2014","unstructured":"Taylor MJ, McNicholas C, Nicolay C, Darzi A, Bell D, Reed JE. Systematic review of the application of the plan-do-study-act method to improve quality in healthcare. BMJ Qual Saf. 2014, 23:290-8. 10.1136\/bmjqs-2013-001862","journal-title":"BMJ Qual Saf"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.107509","article-title":"A fellow-led quality improvement initiative to increase disease activity measurement in a busy academic rheumatology clinic","volume":"18","author":"Lilly M","year":"2026","unstructured":"Lilly M, Memon R, Guinn K, Irwin L, Monga K. A fellow-led quality improvement initiative to increase disease activity measurement in a busy academic rheumatology clinic. Cureus. 2026, 18:e107509. 10.7759\/cureus.107509","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01349-6","article-title":"Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK","volume":"400","author":"Conrad N","year":"2022","unstructured":"Conrad N, Verbeke G, Molenberghs G, et al.. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet (London). 2022, 400:733-43. 10.1016\/S0140-6736(22)01349-6","journal-title":"Lancet (London)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca R","year":"2017","unstructured":"Agca R, Heslinga SC, Rollefstad S, et al.. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis. 2017, 76:17-28. 10.1136\/annrheumdis-2016-209775","journal-title":"Ann Rheum Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22966","article-title":"Implementing an electronic medical record-based reminder for cardiovascular risk screening in rheumatoid arthritis","volume":"69","author":"Akenroye AT","year":"2017","unstructured":"Akenroye AT, Kumthekar AA, Alevizos MK, Mowrey WB, Broder A. Implementing an electronic medical record-based reminder for cardiovascular risk screening in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2017, 69:625-32. 10.1002\/acr.22966","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/NCQ.0000000000000946","article-title":"The hierarchy of intervention effectiveness and its relevance to nursing practice","volume":"41","author":"Nashwan AJ","year":"2026","unstructured":"Nashwan AJ, Atalla AD. The hierarchy of intervention effectiveness and its relevance to nursing practice. J Nurs Care Qual. 2026, 41:210-4. 10.1097\/NCQ.0000000000000946","journal-title":"J Nurs Care Qual"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23612","article-title":"Connecting rheumatology patients to primary care for high blood pressure: specialty clinic protocol improves follow-up and population blood pressures","volume":"71","author":"Bartels CM","year":"2019","unstructured":"Bartels CM, Ramly E, Johnson HM, et al.. Connecting rheumatology patients to primary care for high blood pressure: specialty clinic protocol improves follow-up and population blood pressures. Arthritis Care Res (Hoboken). 2019, 71:461-70. 10.1002\/acr.23612","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000586","article-title":"Quality improvement initiatives in rheumatology: an integrative review of the last 5 years","volume":"31","author":"Liu LH","year":"2019","unstructured":"Liu LH, Choden S, Yazdany J. Quality improvement initiatives in rheumatology: an integrative review of the last 5 years. Curr Opin Rheumatol. 2019, 31:98-108. 10.1097\/BOR.0000000000000586","journal-title":"Curr Opin Rheumatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-016-1633-x","article-title":"Implementation of disease activity measurement for rheumatoid arthritis patients in an academic rheumatology clinic","volume":"16","author":"Bays A","year":"2016","unstructured":"Bays A, Wahl E, Daikh DI, Yazdany J, Schmajuk G. Implementation of disease activity measurement for rheumatoid arthritis patients in an academic rheumatology clinic. BMC Health Serv Res. 2016, 16:384. 10.1186\/s12913-016-1633-x","journal-title":"BMC Health Serv Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-021-00576-4","article-title":"Targeted provider education and pre-visit planning increase rates of formal depression screening in childhood-onset SLE","volume":"19","author":"Mulvihill E","year":"2021","unstructured":"Mulvihill E, Furru R, Goldstein-Leever A, et al.. Targeted provider education and pre-visit planning increase rates of formal depression screening in childhood-onset SLE. Pediatr Rheumatol. 2021, 19:116. 10.1186\/s12969-021-00576-4","journal-title":"Pediatr Rheumatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/09612033261458437","article-title":"A quality improvement project to incorporate the mycophenolate risk evaluation and mitigation strategies in an academic lupus clinic","volume":"35","author":"Cintron D","year":"2026","unstructured":"Cintron D, Pinotti C, Rogers JL, et al.. A quality improvement project to incorporate the mycophenolate risk evaluation and mitigation strategies in an academic lupus clinic. Lupus. 2026, 35:956-64. 10.1177\/09612033261458437","journal-title":"Lupus"},{"key":"ref22","unstructured":"ICD code lists. (2026). Accessed. July 31, 2026: https:\/\/www.cms.gov\/medicare\/coordination-benefits-recovery\/overview\/icd-code-lists."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/499743-improving-lipid-screening-adherence-in-inflammatory-arthritis-using-a-two-cycle-plan-do-study-act-pdsa-quality-improvement-intervention","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:10:14Z","timestamp":1785838214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/499743-improving-lipid-screening-adherence-in-inflammatory-arthritis-using-a-two-cycle-plan-do-study-act-pdsa-quality-improvement-intervention"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.113930","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}